Cargando…
Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma
Due to immunosuppressive properties and confirmed tropism towards cancer cells mesenchymal stromal cells (MSC) have been used in many trials. In our study we used these cells as carriers of IL-12 in the treatment of mice with primary and metastatic B16-F10 melanomas. IL-12 has confirmed anti-cancer...
Autores principales: | Kułach, Natalia, Pilny, Ewelina, Cichoń, Tomasz, Czapla, Justyna, Jarosz-Biej, Magdalena, Rusin, Marek, Drzyzga, Alina, Matuszczak, Sybilla, Szala, Stanisław, Smolarczyk, Ryszard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443548/ https://www.ncbi.nlm.nih.gov/pubmed/34526531 http://dx.doi.org/10.1038/s41598-021-97435-9 |
Ejemplares similares
-
Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context
por: Czapla, Justyna, et al.
Publicado: (2023) -
Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2015) -
Brachytherapy in a Single Dose of 10Gy as an “in situ” Vaccination
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2020) -
The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors
por: Drzyzga, Alina, et al.
Publicado: (2021) -
The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells
por: Czapla, Justyna, et al.
Publicado: (2019)